About Tellus Therapeutics
Tellus Therapeutics is a private company based in Durham, North Carolina, incorporated in 2022 in Delaware. It has reported $18,074,999 raised in three offerings on Form D since January 2019. Its chief executive is Jason Kralic.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2022 | Feb 21, 2023 | $15,999,999of $35.0M target | 1 | $15.9M | EquityRule 506(b) | Form D ↗ |
| May 10, 2021 | Jul 16, 2021 | $2,000,000fully sold | 1 | $2.0M | EquityRule 506(b) | Form D ↗ |
| Jan 21, 2019 | Jan 31, 2019 | $75,000fully sold | 1 | $75,000 | DebtRule 506(b) | Form D ↗ |
| Total, three offerings | $18,074,999 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Tellus Therapeutics's Form D filed Feb 21, 2023.
CG
Chris Garabedian
Director
JK
Jason Kralic
President and Chief Executive Officer, director
EB
Eric Benner
Executive officer and director
FC
Fred Callori
Director
Earlier filings also listed Jason Karlic (executive officer and director, last listed Jan 2019) and Alex Ruckdaeschel (director, last listed Jan 2019).